New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
11:02 EDTACTActavis enters joint development agreement with Particle Sciences
Particle Sciences, a drug delivery Contract Development and Manufacturing Organization, or CDMO, announced that they have entered into an exclusive agreement with Actavis to develop an unnamed complex generic product. Under the agreement, Particle Sciences is responsible for design, formulation and cGMP supplies. Actavis will have responsibility for clinical testing, regulatory filings and marketing. Under the terms of the agreement, Particle Sciences will receive undisclosed milestone and revenue- based payments.
News For ACT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ACT

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use